Clinical Trials

NeuroRobotics is potentially applicable to a broad range of neurological conditions that impair a person's mobility. Through partnerships with Boston-area hospitals, early testing of NeuroRobotics has been conducted on stroke patients and individuals with spinal cord injuries.

With a focus on broadening the technology's application, Myomo engages with leading clinics in research involving stroke as well as other neurological and physiological disorders. The Company is pursuing research and treatment partnerships that will advance understanding of rehabilitation theory, and efficacy of the Myomo e100 NeuroRobotic System in mixed therapy rehabilitation, functional task based rehabilitation, neurological function and other related areas.